Your browser doesn't support javascript.
loading
Visual memory tests enhance the identification of amnestic MCI cases at greater risk of Alzheimer's disease.
Oltra-Cucarella, Javier; Sánchez-SanSegundo, Miriam; Lipnicki, Darren M; Crawford, John D; Lipton, Richard B; Katz, Mindy J; Zammit, Andrea R; Scarmeas, Nikolaos; Dardiotis, Efthimios; Kosmidis, Mary H; Guaita, Antonio; Vaccaro, Roberta; Kim, Ki Woong; Han, Ji Won; Kochan, Nicole A; Brodaty, Henry; Pérez-Vicente, José A; Cabello-Rodríguez, Luis; Sachdev, Perminder S; Ferrer-Cascales, Rosario.
Afiliación
  • Oltra-Cucarella J; Department of Health Psychology, University of Alicante, Alicante, Spain.
  • Sánchez-SanSegundo M; Unit of Cognitive Impairments and Movement Disorders, Hospital General Universitario Santa María del Rosell, Cartagena, Spain.
  • Lipnicki DM; Department of Health Psychology, University of Alicante, Alicante, Spain.
  • Crawford JD; Centre for Healthy Brain Ageing, School of Psychiatry, NPI, Euroa Centre, UNSW Medicine, Randwick, New South Wales, Australia.
  • Lipton RB; Centre for Healthy Brain Ageing, School of Psychiatry, NPI, Euroa Centre, UNSW Medicine, Randwick, New South Wales, Australia.
  • Katz MJ; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Zammit AR; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Scarmeas N; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Dardiotis E; Department of Neurology, Medical Center, Columbia University, New York, NY, USA.
  • Kosmidis MH; Department of Medicine, 1st Neurology Clinic, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Guaita A; Neurology Department, University Hospital of Larissa, University of Thessaly, Volos, Greece.
  • Vaccaro R; Laboratory of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Kim KW; "Golgi Cenci" Foundation, Abbiategrasso, Italy.
  • Han JW; "Golgi Cenci" Foundation, Abbiategrasso, Italy.
  • Kochan NA; Department of Psychiatry, Bundang Hospital, Seoul National University, Gyeonggi-do, Korea.
  • Brodaty H; Department of Brain and Cognitive Science, College of Natural Sciences, Seoul National University, Seoul, Korea.
  • Pérez-Vicente JA; Department of Psychiatry, College of Medicine, Seoul National University, Seoul, Korea.
  • Cabello-Rodríguez L; Department of Psychiatry, Bundang Hospital, Seoul National University, Gyeonggi-do, Korea.
  • Sachdev PS; Centre for Healthy Brain Ageing, School of Psychiatry, NPI, Euroa Centre, UNSW Medicine, Randwick, New South Wales, Australia.
  • Ferrer-Cascales R; Centre for Healthy Brain Ageing, School of Psychiatry, NPI, Euroa Centre, UNSW Medicine, Randwick, New South Wales, Australia.
Int Psychogeriatr ; 31(7): 997-1006, 2019 Jul.
Article en En | MEDLINE | ID: mdl-30355384
ABSTRACT

OBJECTIVES:

To investigate whether amnestic mild cognitive impairment (aMCI) identified with visual memory tests conveys an increased risk of Alzheimer's disease (risk-AD) and if the risk-AD differs from that associated with aMCI based on verbal memory tests.

PARTICIPANTS:

4,771 participants aged 70.76 (SD = 6.74, 45.4% females) from five community-based studies, each a member of the international COSMIC consortium and from a different country, were classified as having normal cognition (NC) or one of visual, verbal, or combined (visual and verbal) aMCI using international criteria and followed for an average of 2.48 years. Hazard ratios (HR) and individual patient data (IPD) meta-analysis analyzed the risk-AD with age, sex, education, single/multiple domain aMCI, and Mini-Mental State Examination (MMSE) scores as covariates.

RESULTS:

All aMCI groups (n = 760) had a greater risk-AD than NC (n = 4,011; HR range = 3.66 - 9.25). The risk-AD was not different between visual (n = 208, 17 converters) and verbal aMCI (n = 449, 29 converters, HR = 1.70, 95%CI 0.88, 3.27, p = 0.111). Combined aMCI (n = 103, 12 converters, HR = 2.34, 95%CI 1.13, 4.84, p = 0.023) had a higher risk-AD than verbal aMCI. Age and MMSE scores were related to the risk-AD. The IPD meta-analyses replicated these results, though with slightly lower HR estimates (HR range = 3.68, 7.43) for aMCI vs. NC.

CONCLUSIONS:

Although verbal aMCI was most common, a significant proportion of participants had visual-only or combined visual and verbal aMCI. Compared with verbal aMCI, the risk-AD was the same for visual aMCI and higher for combined aMCI. Our results highlight the importance of including both verbal and visual memory tests in neuropsychological assessments to more reliably identify aMCI.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int Psychogeriatr Asunto de la revista: GERIATRIA / PSIQUIATRIA Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int Psychogeriatr Asunto de la revista: GERIATRIA / PSIQUIATRIA Año: 2019 Tipo del documento: Article País de afiliación: España